IP Library Granted Patent US 7,414,141
Granted Patent B2
US 7,414,141 · App. 10/563,459 · Granted Aug 19, 2008

Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin

Assignee: Avecia Pharmaceuticals, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,414,141
App. No.
10/563,459
Granted
Aug 19, 2008
Kind
B2
Abstract

There is provided a process for the preparation of a compound of formula (7) or salts thereof: wherein R 1 represents a hydrogen or a hydrocarbyl group, R 2 represents a hydrogen or substituent group, R 3 represents a hydrogen or a hydrocarbyl group, and X represents a hydrogen or substituent group which comprises a) cyanating a compound of formula (1): wherein Y represents a halo group, preferably CI or Br; P 1 represents hydrogen or a protecting group, and W represents =0 or —OP 2 , in which P 2 represents hydrogen or a protecting group, to give a compound of formula (2): b) reducing the compound of formula (2) to give a compound of formula (3): coupling the compound of formula (3) with a compound of formula (4): to give a compound of formula (5): when W represents —OP 2 , deprotecting and then oxidising the compound of formula (5) to give a compound of formula (6): and e) subjecting the compound of formula (5) when W represents ═O, or compound of formula (6) to ring-opening, and removal of any remaining protecting groups, to give a compound of formula (7) or salts thereof

Claims (20)

1. A compound of formula (5):

wherein

R 1 represents an alkyl group;

R 2 represents an aryl group;

R 3 represents an aryl group;

X represents a group of formula —COZ, wherein Z represents —OR 4 , in which R 4 represents an alkyl, or —NR 5 R 6 , wherein R 5 and R 6 each independently represent H, alkyl, or aryl;

P 1 represents hydrogen or a protecting group; and

W represents —OP 2 , in which P 2 represents hydrogen or a protecting group.

2. The compound of claim 1 , wherein R 1 represents a C 1-6 alkyl group.

3. The compound of claim 1 , wherein R 1 represents an isopropyl group.

4. The compound of claim 1 , wherein R 2 represents a phenyl group.

5. The compound of claim 1 , wherein R 3 represents a 4-fluorophenyl group.

6. The compound of claim 1 , wherein Z represents -OR 4 , in which R 4 represents an alkyl.

7. The compound of claim 1 , wherein Z represents -OR 4 , in which R 4 represents a methyl or ethyl group.

8. The compound of claim 1 , wherein Z represents -NR 5 R 6 , wherein R 5 and R 6 each independently represent H, alkyl, or aryl.

9. The compound of claim 1 , wherein Z represents -NR 5 R 6 , wherein R 5 is H and R 6 is phenyl.

10. The compound of claim 1 , wherein R 1 represents a C 1-6 alkyl group; and R 2 represents a phenyl group.

11. The compound of claim 1 , wherein R 1 represents a C 1-6 alkyl group; R 2 represents a phenyl group; and R 3 represents a 4-fluorophenyl group.

12. The compound of claim 1 , wherein R 1 represents a C 1-6 alkyl group; R 2 represents a phenyl group; R 3 represents a 4-fluorophenyl group; and Z represents -OR 4 , in which R 4 represents a methyl or ethyl group.

13. The compound of claim 1 , wherein R 1 represents a C 1-6 alkyl group; R 2 represents a phenyl group; R 3 represents a 4-fluorophenyl group; and Z represents -NR 5 R 6 , wherein R 5 is H and R 6 is phenyl.

Assignments (6)
CHANGE OF NAME Recorded Apr 17, 2015
From: REDX PHARMA LIMITED
To: REDX PHARMA PLC
Reel/Frame 035455/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2011
From: BRADFORD PHARMA LIMITED
To: REDX PHARMA LIMITED
Reel/Frame 027221/0001 →
CHANGE OF NAME Recorded Mar 3, 2010
From: NPIL PHARMACEUTICALS (UK) LIMITED
To: PIRAMAL HEALTHCARE UK LIMITED
Reel/Frame 024021/0384 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2010
From: PIRAMAL HEALTHCARE UK LIMITED
To: BRADFORD PHARMA LIMITED
Reel/Frame 024021/0412 →
CHANGE OF NAME Recorded May 15, 2008
From: AVECIA PHARMACEUTICALS LIMITED
To: NPIL PHARMACEUTICALS (UK) LIMITED
Reel/Frame 020949/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2006
From: MOODY, DAVID J.; WIFFEN, JONATHAN W.
To: AVECIA PHARMACEUTICALS LIMITED
Reel/Frame 017973/0123 →
Priority Claims (2)
GB 0317393.7 · Jul 25, 2003 · national
GB 0406760.9 · Mar 26, 2004 · national
Continuity (1)
Related Publication 20070043221A1 · Feb 22, 2007